Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1981 2
1982 5
1983 2
1984 2
1985 3
1986 7
1987 1
1988 2
1989 2
1991 2
1992 6
1993 6
1994 9
1995 13
1996 21
1997 20
1998 17
1999 20
2000 30
2001 26
2002 36
2003 51
2004 51
2005 60
2006 63
2007 77
2008 103
2009 105
2010 123
2011 125
2012 174
2013 221
2014 223
2015 257
2016 263
2017 285
2018 319
2019 402
2020 532
2021 614
2022 704
2023 708
2024 260

Text availability

Article attribute

Article type

Publication date

Search Results

5,307 results

Results by year

Filters applied: . Clear all
Page 1
Safety and antitumour activity of cadonilimab, an anti-PD-1/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b/2 trial.
Gao X, Xu N, Li Z, Shen L, Ji K, Zheng Z, Liu D, Lou H, Bai L, Liu T, Li Y, Li Y, Fan Q, Feng M, Zhong H, Huang Y, Lou G, Wang J, Lin X, Chen Y, An R, Li C, Zhou Q, Huang X, Guo Z, Wang S, Li G, Fei J, Zhu L, Zhu H, Li X, Li F, Liao S, Min Q, Tang L, Shan F, Gong J, Gao Y, Zhou J, Lu Z, Li X, Li J, Ren H, Liu X, Yang H, Li W, Song W, Wang ZM, Li B, Xia M, Wu X, Ji J. Gao X, et al. Among authors: zhong h. Lancet Oncol. 2023 Oct;24(10):1134-1146. doi: 10.1016/S1470-2045(23)00411-4. Lancet Oncol. 2023. PMID: 37797632 Clinical Trial.
APR-246 increases tumor antigenicity independent of p53.
Michels J, Venkatesh D, Liu C, Budhu S, Zhong H, George MM, Thach D, Yao ZK, Ouerfelli O, Liu H, Stockwell BR, Campesato LF, Zamarin D, Zappasodi R, Wolchok JD, Merghoub T. Michels J, et al. Among authors: zhong h. Life Sci Alliance. 2023 Oct 27;7(1):e202301999. doi: 10.26508/lsa.202301999. Print 2024 Jan. Life Sci Alliance. 2023. PMID: 37891002 Free PMC article.
Research progress on the pathogenesis of diabetic retinopathy.
Li H, Liu X, Zhong H, Fang J, Li X, Shi R, Yu Q. Li H, et al. Among authors: zhong h. BMC Ophthalmol. 2023 Sep 11;23(1):372. doi: 10.1186/s12886-023-03118-6. BMC Ophthalmol. 2023. PMID: 37697295 Free PMC article. Review.
GPCR signaling contributes to immune characteristics of microenvironment and process of EBV-induced lymphomagenesis.
Xiong J, Dai YT, Wang WF, Zhang H, Wang CF, Yin T, Cheng S, Zhong HJ, Yu SH, Jiang L, Wang SY, Fang H, Zhang RH, Zhu Y, Yi HM, Jiang XF, Chen JY, Wang L, Xu PP, Chen SJ, Zhao WL. Xiong J, et al. Among authors: zhong hj. Sci Bull (Beijing). 2023 Nov 15;68(21):2607-2619. doi: 10.1016/j.scib.2023.09.029. Epub 2023 Sep 22. Sci Bull (Beijing). 2023. PMID: 37798178 Free article.
5,307 results